IP Library Granted Patent US 12,507,923
Granted Patent B2
US 12,507,923 · App. 17/934,087 · Granted Dec 30, 2025

Analyte sensor and a method for producing an analyte sensor

Inventors: Gernot Hochmuth (Mannheim, DE); Kirill Sliozberg (Mannheim, DE); Alexander Steck (Hirschberg, DE)
Assignee: Roche Diabetes Care, Inc.
A61B5/14865A61B5/14532G01N27/3275
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,507,923
App. No.
17/934,087
Granted
Dec 30, 2025
Kind
B2
Abstract

A fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid has a substrate with a first surface configured to face towards the body fluid. The sensor has a working electrode and an interferent electrode. The interferent electrode and the working electrode are electrically separated layers located adjacently on the first surface. The sensor has a further electrode, the further electrode being a counter electrode, a reference electrode or a counter/reference electrode. The working electrode and the interferent electrode each have a layer of a conductive material. The working electrode has an enzyme whereas the interferent electrode is devoid of enzyme. A method for producing the fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid is also disclosed.

Claims (36)

1 . A fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid, the sensor comprising:

a substrate having a first surface configured to face towards the body fluid;

a working electrode;

an interferent electrode, wherein the interferent electrode and the working electrode are electrically separated and located adjacently on the first surface; and

a further electrode selected from the group consisting of a counter electrode, a reference electrode and a counter/reference electrode;

wherein (i) the working electrode and the interferent electrode each have a layer of a conductive material, (ii) the working electrode further comprises a composition having an enzyme and a carrier, and (iii) the interferent electrode is devoid of the enzyme and the carrier; and

wherein the working electrode is surrounded by the interferent electrode to the extent sufficient to cause the interferents reacting with the working electrode to be reduced such that additional calculations of the interferent current are not necessary to determine the analyte concentration.

2 . The analyte sensor according to claim 1 , wherein the substrate has a second surface facing away from the first surface, wherein the further electrode is located on the second surface of the substrate.

3 . The analyte sensor according to claim 1 , further comprising a diffusion limiting membrane covering at least the working electrode.

4 . The analyte sensor according to claim 3 , wherein the diffusion limiting membrane covers both the working electrode and the interferent electrode.

5 . The analyte sensor according to claim 3 , wherein a thickness of the diffusion limiting membrane exceeds a diameter of the working electrode.

6 . The analyte sensor according to claim 5 , wherein the thickness of the diffusion limiting membrane is in the range of 20 μm to 50 μm.

7 . The analyte sensor according to claim 3 , wherein the working electrode and the interferent electrode are separated from each other by a distance in the range of 0.5 to 2.0 times the thickness of the diffusion limiting membrane.

8 . The analyte sensor according to claim 1 , wherein the interferent electrode is operable at the same potential applied to the working electrode.

9 . The analyte sensor according to claim 1 , wherein the analyte comprises glucose and the enzyme is at least one of glucose oxidase or glucose dehydrogenase.

10 . The implantable sensor according to claim 1 , wherein the interferent electrode substantially surrounds the working electrode.

11 . A method for producing a fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid, the method comprising:

a) applying a layer of a conductive material to a first surface of a substrate, the first surface being configured to face towards a body fluid, wherein the layer is applied so that two electrically separated layers located adjacent to one another are obtained in a first portion of the first surface and a second portion of the first surface, respectively;

b) applying onto the conductive material a layer of a composition comprising an enzyme and a carrier such that a working electrode is formed on the first portion covered by the composition and an interferent electrode is formed on the second portion and the interferent electrode is devoid of the enzyme and the carrier, wherein the working electrode is surrounded by the interferent electrode to the extent sufficient to cause the interferents reacting with the working electrode to be reduced such that additional calculations of the interferent current are not necessary to determine the analyte concentration; and

c) forming on the substrate at least one further electrode selected from the group consisting of a counter electrode, a reference electrode and a counter/reference electrode.

12 . The method according to claim 11 , wherein step a) comprises:

applying a first individual layer of the conductive material onto the first portion and a second individual layer of the conductive material onto the second portion such that the first portion and the second portion are electrically separated from each other; or

applying the layer of the conductive material onto the first surface and removing the conductive material between the first portion and the second portion.

13 . The method according to claim 11 , wherein step b) comprises:

further applying onto the conductive material the layer of the composition on the first portion in a manner that the conductive material on the second portion is maintained devoid of the composition comprising the enzyme; or

further applying onto the conductive material the layer of the composition comprising the enzyme onto the conductive material, subsequently removing the composition comprising the enzyme from the second portion and maintaining the composition comprising the enzyme on the first portion.

14 . The method according to claim 11 , wherein step c) comprises applying a second layer of the conductive material to a second surface of the substrate, the second surface facing away from the first surface.

15 . The method according to claim 11 , wherein the interferent electrode substantially surrounds the working electrode.

16 . A fully or partially implantable analyte sensor for continuously monitoring analyte concentration in a body fluid, the sensor comprising:

a substrate having a first surface configured to face towards the body fluid;

a working electrode;

an interferent electrode, wherein the interferent electrode and the working electrode are electrically separated and located adjacently on the first surface; and

a further electrode selected from the group consisting of a counter electrode, a reference electrode and a counter/reference electrode;

wherein (i) the working electrode and the interferent electrode each have a layer of a conductive material, (ii) the working electrode further comprises at least one enzyme, and (iii) the interferent electrode is devoid of enzyme, wherein the working electrode is surrounded by the interferent electrode to the extent sufficient to cause the interferents reacting with the working electrode to be reduced such that additional calculations of the interferent current are not necessary to determine analyte concentration; and

wherein the conductive material of the interferent electrode and the working electrode is the same.

17 . The implantable analyte sensor of claim 16 , wherein the interferent electrode substantially surrounds the working electrode.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2022
From: HOCHMUTH, GERNOT; STECK, ALEXANDER; SLIOZBERG, KYRYLO
To: ROCHE DIABETES CARE GMBH
Reel/Frame 061789/0170 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2022
From: ROCHE DIABETES CARE GMBH
To: ROCHE DIABETES CARE, INC.
Reel/Frame 061949/0832 →
Priority Claims (1)
EP 20181542 · Jun 23, 2020 · regional
Continuity (2)
Continuation PCTEP2021066854 · Jun 21, 2021
Related Publication 20230051071A1 · Feb 16, 2023
References Cited (54)
US 3847370A · Engelsher · 1974 [cited by applicant]
US 5413690A · Kost et al. · 1995 [cited by applicant]
US 5762770A · Pritchard et al. · 1998 [cited by applicant]
US 5798031A · Charlton et al. · 1998 [cited by applicant]
US 6129823A · Hughes et al. · 2000 [cited by applicant]
US 6360888B1 · McIvor et al. · 2002 [cited by applicant]
US 7653492B2 · Davies · 2010 [cited by examiner]
US 10335520B2 · Phillips et al. · 2019 [cited by applicant]
US 20040111017A1 · Say et al. · 2004 [cited by applicant]
US 20050013731A1 · Burke et al. · 2005 [cited by applicant]
US 20070213611A1 · Simpson et al. · 2007 [cited by applicant]
US 20080073207A1 · Teodorczyk et al. · 2008 [cited by applicant]
US 20080179187A1 · Ouyang et al. · 2008 [cited by applicant]
US 20080242962A1 · Roesicke et al. · 2008 [cited by applicant]
US 20090156920A1 · Kotzan et al. · 2009 [cited by applicant]
US 20090312614A1 · Brenneman · 2009 [cited by applicant]
US 20100270175A1 · Pei et al. · 2010 [cited by applicant]
US 20110259741A1 · Murase et al. · 2011 [cited by applicant]
US 20120323098A1 · Moein · 2012 [cited by examiner]
US 20130131478A1 · Simpson et al. · 2013 [cited by applicant]
US 20130199944A1 · Petisee · 2013 [cited by examiner]
US 20140318986A1 · Elder et al. · 2014 [cited by applicant]
US 20150001070A1 · Mackintosh · 2015 [cited by applicant]
US 20150241378A1 · Liu et al. · 2015 [cited by applicant]
US 20160235347A1 · Baig · 2016 [cited by examiner]
US 20170042480A1 · Gandhi · 2017 [cited by examiner]
US 20190004000A1 · Jang · 2019 [cited by examiner]
US 20190079044A1 · Ringemann · 2019 [cited by examiner]
US 20200037932A1 · Lucisano · 2020 [cited by examiner]
US 20210030324A1 · Huang et al. · 2021 [cited by applicant]
AR 058552A1 · 2008 [cited by applicant]
AU 2020210301B2 · 2021 [cited by applicant]
CN 111096754A · 2020 [cited by applicant]
EP 1797817A1 · 2007 [cited by applicant]
EP 2261646A1 · 2010 [cited by applicant]
EP 3444602A1 · 2019 [cited by applicant]
EP 3771410A1 · 2021 [cited by applicant]
JP 2003503090A · 2003 [cited by applicant]
JP 2004184155A · 2004 [cited by applicant]
JP 2011242385A · 2011 [cited by applicant]
JP 2012531947A · 2014 [cited by applicant]
KR 1020160049340A · 2016 [cited by applicant]
KR 102173496B1 · 2020 [cited by applicant]
RU 2485887C2 · 2013 [cited by applicant]
RU 2622087C2 · 2017 [cited by applicant]
RU 2669550C2 · 2018 [cited by applicant]
RU 2686463C2 · 2019 [cited by applicant]
TW 202107078A · 2021 [cited by applicant]
WO WO0078992A2 · 2000 [cited by applicant]
WO WO2014037745A1 · 2014 [cited by applicant]
WO WO2017157894A1 · 2017 [cited by applicant]
WO WO2021023125A1 · 2021 [cited by applicant]
International Search Report and Written Opinion of the International Searching Authority, PCT/EP2021/066854, Sep. 3, 2021, 12 pages. [cited by applicant]
Third Party Observations Concerning Patentability of Invention, EP 20181542.0, Jul. 6, 2023, 32 pages. [cited by applicant]